|Short Name:||ADCOCK||JSE Code:||AIP|
|Nature of business:|
Adcock Ingram is a leading South African pharmaceutical manufacturer, listed on the Johannesburg Stock Exchange. Adcock Ingram manufactures, markets and distributes a wide range of healthcare products. The company is a leading supplier to both the private and public sectors of the market. Adcock Ingram is a level 4 B-BBEE contributor. Expansion in to emerging markets has given the company a presence in sub-Saharan Africa and India.
Next AGM: 22/11/2019 (Unconfirmed)
|Amounts in ZAR '000||JUN 2018|
|Turnover ||6 562 865||3 213 752|
|Operating Income ||819 482||403 660|
|Income Attributable To Equity Holders ||637 943||320 322|
|Earnings Per Share (ZARc) per share (cents)||383.60||192.60|
|Headline Earnings Per Share (Cont Ops) (ZARc) per share (cents)||387.70||192.60|
|Distributions Per Share (ZARc) per share (cents)||172.00||86.00|
|Ordinary Shareholders' Interest ||3 912 506||3 656 442|
|Total Long-Term Liabilities ||135 254||73 707|
|Fixed Assets ||1 521 255||1 459 029|
|Net Asset Value Per Share (ZARc) (cents)||2 226.20||2 080.50|
Click here for disclaimer.
Sharedata provided by Profile.